Amygdalin extracts from almonds and apricots as anticancer agents in human oral carcinoma - an in vitro investigation

Background: In recent years, the application of complementary medicine to treat an array of conditions, including cancer, has surged in prominence. Investigations have indicated that amygdalin, a naturally occurring chemical derived from plants, has anticarcinogenic impacts on several types of cancer. Method: The current work used human oral cancer cell lines, namely the oral cell line SCC-9, to evaluate the anticarcinogenic impact of amygdalin extracted from almonds and apricots. A meticulous extraction method from fresh apricots and almonds was employed to accomplish this. After that, SCC-9 cells were treated with these extracts at different doses ranging from 0 to 100 μg/ml. Acridine orange/ethidium bromide staining, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test, and neutral red uptake assay (NRU) were used to assess the effectiveness of amygdalin. Conclusion: The findings demonstrated the anti-cancer qualities of amygdalin, which is found in almonds and apricots. This demonstrates that it is a therapeutic strategy which can be helpful in treating oral cancer.